Naringenin attenuates non‐alcoholic fatty liver disease by down‐regulating the NLRP3/NF‐κB pathway in mice
British Journal of Pharmacology2019Vol. 177(8), pp. 1806–1821
Citations Over TimeTop 10% of 2019 papers
Qinyu Wang, Yangjie Ou, Guomin Hu, Cong Wen, Shanshan Yue, Cong Chen, Lu Xu, Jiawei Xie, Hui Dai, Han Xiao, Youyi Zhang, Rong Qi
Abstract
Naringenin prevented NAFLD via down-regulating the NLRP3/NF-κB signalling pathway both in KCs and in hepatocytes, thus attenuating inflammation in the mice livers.
Related Papers
- → Estrogenic Activity of the Phytoestrogens Naringenin, 6-(1,1-Dimethylallyl)naringenin and 8-Prenylnaringenin(2002)109 cited
- → Stimulation of Melanogenesis by the Citrus Flavonoid Naringenin in Mouse B16 Melanoma Cells(2006)51 cited
- Inhibitory Effects of Naringenin and Its Novel Derivatives on Hyaluronidase(2009)
- → Accumulation of dietary naringenin and metabolites in mice(2013)3 cited
- 보문 : Naringenin이 NF-κB, AP-1 억제를 통한 MMP-9 활성 및 발현 억제 효과(2009)